CircPRRC2C Promotes the Oncogenic Phenotypes of Laryngeal Squamous Cell Carcinoma Cells Via MiR-136-5p/HOXD11 Axis

Overview

Journal Mol Biotechnol

Publisher Springer

Specialties Biotechnology
Molecular Biology

Date 2023 Sep 20

PMID 37728841

Authors

Xiu Peng

Xintian Chen

Shuai Peng

Yingming Chen

Yong Li

Yang Tian

Affiliations

Soon will be listed here.

Abstract

The involvement of circular RNAs (circRNAs) in laryngeal squamous cell carcinoma (LSCC) carcinogenesis has gradually been proposed. Herein, we aimed to explore the function and mechanism of circPRRC2C in LSCC. Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting were used for detecting the content of genes and proteins. In vitro experiments were conducted using 5-ethynyl-2'-deoxyuridine, colony formation, flow cytometry, and transwell assays. The binding between miR-136-5p and circPRRC2C or Homeobox D11 (HOXD11) was confirmed by using the dual-luciferase reporter assay. The murine xenograft model was established for in vivo analysis. The commercial kit was used for exosome separation. CircPRRC2C is a stable circRNA, and was highly expressed in LSCC tissues and cell lines. Functionally, circPRRC2C deficiency impaired LSCC cell proliferation, migration and invasion but induced cell apoptosis in vitro and impeded tumor growth in vivo, however, circPRRC2C overexpression showed the exact opposite effects. Mechanistically, circPRRC2C directly targeted miR-136-5p, which showed inhibitory effects on the growth and mobility of LSCC cells. Meanwhile, miR-136-5p directly targeted HOXD11, and circPRRC2C/miR-136-5p/HOXD11 formed a feedback loop in LSCC cells. Further rescue assays exhibited that circPRRC2C exerted its effects by miR-136-5p/HOXD11 axis. In addition, circPRRC2C was stably packaged into exosomes and showed potential diagnostic value for LSCC. CircPRRC2C acted as an oncogene to promote LSCC cell oncogenic phenotypes via miR-136-5p/HOXD11 axis, besides, circPRRC2C was stably packaged into exosomes, indicating the potential application of circPRRC2C-targeting agents in the treatment in LSCC.

Citing Articles

Hsa_circYARS interacts with miR-29a-3p to up-regulate IREB2 and promote laryngeal squamous cell carcinoma progression.

Guo Z, Zhao Y, Guo N, Xu M, Wang X Discov Oncol. 2024; 15(1):401.

PMID: 39225900 PMC: 11371998. DOI: 10.1007/s12672-024-01198-4.

References

Cavaliere M, Bisogno A, Scarpa A, DUrso A, Marra P, Colacurcio V . Biomarkers of laryngeal squamous cell carcinoma: a review. Ann Diagn Pathol. 2021; 54:151787. DOI: 10.1016/j.anndiagpath.2021.151787. View

Zappavigna S, Cossu A, Abate M, Misso G, Lombardi A, Caraglia M . A Hydroquinone-Based Derivative Elicits Apoptosis and Autophagy via Activating a ROS-Dependent Unfolded Protein Response in Human Glioblastoma. Int J Mol Sci. 2019; 20(15). PMC: 6696486. DOI: 10.3390/ijms20153836. View

Yang Q, Deng Y . Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers. Int J Clin Exp Pathol. 2014; 7(4):1286-92. PMC: 4014209. View

Koontongkaew S . The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer. 2013; 4(1):66-83. PMC: 3564248. DOI: 10.7150/jca.5112. View

Zhang Z, Yang T, Xiao J . Circular RNAs: Promising Biomarkers for Human Diseases. EBioMedicine. 2018; 34:267-274. PMC: 6116471. DOI: 10.1016/j.ebiom.2018.07.036. View

Li H, Peng K, Yang K, Ma W, Qi S, Yu X . Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics. 2022; 12(14):6422-6436. PMC: 9475446. DOI: 10.7150/thno.77350. View

Li W, Liu J, Chen M, Xu J, Zhu D . Circular RNA in cancer development and immune regulation. J Cell Mol Med. 2020; 26(6):1785-1798. PMC: 8918416. DOI: 10.1111/jcmm.16102. View

Gao W, Guo H, Niu M, Zheng X, Zhang Y, Xue X . circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer. 2020; 19(1):166. PMC: 7686732. DOI: 10.1186/s12943-020-01279-2. View

Tian L, Cao J, Jiao H, Zhang J, Ren X, Liu X . CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis. Clin Sci (Lond). 2019; 133(9):1053-1066. DOI: 10.1042/CS20190110. View

10.

Hansen T, Jensen T, Clausen B, Bramsen J, Finsen B, Damgaard C . Natural RNA circles function as efficient microRNA sponges. Nature. 2013; 495(7441):384-8. DOI: 10.1038/nature11993. View

11.

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

12.

Zhou Z, Huang G, Fu Q, Han B, Lu J, Chen A . circRNA.33186 Contributes to the Pathogenesis of Osteoarthritis by Sponging miR-127-5p. Mol Ther. 2019; 27(3):531-541. PMC: 6402950. DOI: 10.1016/j.ymthe.2019.01.006. View

13.

Cooks T, Pateras I, Jenkins L, Patel K, Robles A, Morris J . Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nat Commun. 2018; 9(1):771. PMC: 5823939. DOI: 10.1038/s41467-018-03224-w. View

14.

Chen C, Luo F, Liu X, Lu L, Xu H, Yang Q . NF-kB-regulated exosomal miR-155 promotes the inflammation associated with arsenite carcinogenesis. Cancer Lett. 2016; 388:21-33. DOI: 10.1016/j.canlet.2016.11.027. View

15.

Jung E, Seong Y, Jeon B, Song H, Kwon Y . Global analysis of AGO2-bound RNAs reveals that miRNAs induce cleavage of target RNAs with limited complementarity. Biochim Biophys Acta Gene Regul Mech. 2017; 1860(11):1148-1158. DOI: 10.1016/j.bbagrm.2017.10.001. View

16.

He A, Liu J, Li F, Yang B . Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduct Target Ther. 2021; 6(1):185. PMC: 8137869. DOI: 10.1038/s41392-021-00569-5. View

17.

Smith C, Prasad V . Targeted Cancer Therapies. Am Fam Physician. 2021; 103(3):155-163. View

18.

Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F . Molecular targeting therapies for neuroblastoma: Progress and challenges. Med Res Rev. 2020; 41(2):961-1021. PMC: 7906923. DOI: 10.1002/med.21750. View

19.

Kara G, Calin G, Ozpolat B . RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev. 2022; 182:114113. DOI: 10.1016/j.addr.2022.114113. View

20.

Yin X, Wang J, Shan C, Jia Q, Bian Y, Zhang H . Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p. Bioengineered. 2022; 13(3):6929-6941. PMC: 8973624. DOI: 10.1080/21655979.2022.2034703. View